Your session is about to expire
← Back to Search
Radiation Therapy for Prostate Cancer
Study Summary
This trial is testing whether delivering radiation in higher doses over a shorter time period is more effective at treating prostate cancer with fewer side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 trial • 107 Patients • NCT03324802Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Frequently Asked Questions
Has Hypofractionated Radiation Therapy undergone approval by the US Federal Drug Administration?
"There is both supporting efficacy data and multiple rounds of safety data, so Hypofractionated Radiation Therapy received a score of 3."
How many people are currently participating in this research?
"That is accurate. The information available on clinicaltrials.gov shows that this clinical trial is still looking for participants. It was originally posted on 5/30/2019, and the most recent update was on 9/29/2022. They are hoping to have 178 people join from 3 different sites."
Are patients currently being enrolled in this trial?
"That is accurate. The information available on clinicaltrials.gov affirms that this trial, which was first publicized on May 30th 2019, is still looking for participants. There are 3 different hospitals where a total of 178 patients can be enrolled in the study."
Share this study with friends
Copy Link
Messenger